Hybrigenics

View in Terminal

Loading quotes...

Forecast

There is no analyst data available for this company.

Discussions in the community

There is no discussion about this asset yet.

Start discussion

News Go to news feed

There is currently no news available for this company. We are working on adding more providers to change this.

Financials

In the last year, Hybrigenics had revenue of €383.8K and net profit of -€18.85M

(EUR)	2023	YoY
Revenue	383.8K	24,502.63%
Gross profit	-146.38K	61.99%
Net profit	-18.85M	3,244.13%
EBITDA	-450.67K	11.24%

Fundamentals

Metric	Value
Market capitalization	€3.95M
Number of shares	383.15M
52-week high/low	€0.0658 - €0.0085
Dividends	No
Beta	1.08
P/E ratio	-6.60
PEG ratio	-0.07
P/B ratio	144.70
P/S ratio	11.27

Company profile

Hybrigenics SA, together with its subsidiaries, operates as a biotechnology company in France. The company engages in development of biotechnology in the field of biotechnology, oncology, regenerative medicine, and anti-aging medicine. It is also involved in the development of technical solutions using adipose tissue cells and stem cells. The company is headquartered in Gallargues-le-Montueux, France. Hybrigenics SA is a subsidiary of Diagnostic Medical Systems S.A.